DDR2 (discoidin domain receptor 2) suppresses osteoclastogenesis and is a potential therapeutic target in osteoporosis. [electronic resource]
- Science signaling Mar 2015
- ra31 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't